milvexian (BMS-986177) - BMS, J&J
Milvexian: Data readout from P3 LIBREXIA-STROKE trial (NCT05702034) for secondary stroke prevention in 2026 (43rd Annual J.P. Morgan Healthcare Conference, Bristol-Myers Squibb) - Jan 13, 2025 - Data readout from P3 LIBREXIA-ACS trial (NCT05754957) for acute coronary syndrome in 2026 
P3 data Acute Coronary Syndrome • Cardiovascular • Ischemic stroke
https://www.bms.com/assets/bms/us/en-us/pdf/investor-info/doc_presentations/2025/BMS-JPM-2025-presentation.pdf
 
Jan 13, 2025
 
 
d68ad212-2214-43bb-9b8d-d6f8ca1ab6b2.png